Explore 5 years of NHS prescribing data. We’re helping to make prescribing safer and more cost-effective.
We are improving medicine with evidence and data
We are the Evidence-Based Medicine DataLab, at the University of Oxford.
We build innovative, live tools to help make science and healthcare data more impactful in the real world.
We campaign for better, transparent, timely and accessible information in healthcare.
We’re looking closely at how clinical trials are conducted and reported, to ensure health care providers and patients have the most complete and accurate view of the evidence impacting their health.
The EU TrialsTracker, which provides the results reporting status of every trial on the EU Clinical Trials Registry, launched last week alongside a paper in the BMJ. We … [Read More...] about IQWiG Response to the EU TrialsTracker
Earlier this year we launched our FDAAA TrialsTracker, providing a live look at whether individual sponsors and trialists are meeting their responsibility to report the … [Read More...] about The EU TrialsTracker is Live!
Our FDAAA TrialsTracker has been updating each working day since February showing which trials on ClinicalTrials.gov have reported, in compliance with the FDA Amendments Act … [Read More...] about TrialsTracker Project Wins Cochrane-REWARD Prize for Reducing Research Waste
Recently we created antimicrobial stewardship dashboards for every Clinical Commissioning Group and General Practice in England by grouping our measures (see our blog post … [Read More...] about Smoothing seasonality – your feedback needed
Last week, a pharmacist from NHS North Cumbria CCG got our attention by mentioning OpenPrescribing on Twitter. He had just received a letter about a product for treating … [Read More...] about Could North Cumbria save money on haemorrhoid cream?
[this newsletter was sent out on Thurs, Jul 26; sign up to receive the next one at www.openprescribing.net] We do the stats to make your life easy... At OpenPrescribing we … [Read More...] about OpenPrescribing July newsletter
On February 19, 2018 we launched the FDAAA TrialsTracker, a tool that automatically monitors whether clinical trials are reporting their results to ClinicalTrials.gov in … [Read More...] about FDAAA TrialsTracker Milestones: 6 Months, >1200 trials, $500 Million in Fines
On our OpenPrescribing CCG and practice dashboards you can now filter measures by category to view a small group of related measures together. You can select a category … [Read More...] about New on OpenPrescribing – our measures now have categories!
Updates to OpenPrescribing Thanks largely to our new software developer Dave, we are making some improvements to the site. With the fresh-faced enthusiasm of a new … [Read More...] about OpenPrescribing June Newsletter
Low-Priority Prescribing Paper Published This week our latest paper was published, which describes the trends and variation in prescribing of medicines determined to be of … [Read More...] about OpenPrescribing May Newsletter
This is a brief blog about something small and trivial, but also big and important. Recently on the staircase my friend Carl Heneghan came out with a good line about … [Read More...] about “PPPI”: why academics should engage Patients, the Public *and* Professionals
Homeopathy Paper Published Our new paper asks the question: Is use of homeopathy associated with poor prescribing in English primary care? The answer, yes. We found that … [Read More...] about OpenPrescribing April Newsletter
In February, we posted our first Unreported Trial of the Week here in the Datalab blog highlighting a trial from Columbia University. Since then, that trial has submitted … [Read More...] about Unreported Clinical Trial of the Week Round-Up
Price Concessions – February The Pharmaceutical Services Negotiating Committee (PSNC) have released 3 sets of price concession price lists for February 2018. Once again, the … [Read More...] about OpenPrescribing March Newsletter
Our FDAAA TrialsTracker provides a public list of all trials required to report under the FDA Amendments Act of 2007 (FDAAA). We update every weekday with live data showing … [Read More...] about An unreported clinical trial… from the FDA themselves
The Pharmaceutical Services Negotiating Committee (PSNC) have released 3 sets of price concession price lists for February 2018. Once again, the total amount for England for … [Read More...] about Price concessions for February 2018
When you produce online tools from data, you often get useful feedback that helps you improve the outputs. (Send us feedback any time!). Additionally, when you use data, you … [Read More...] about Making the FDAAA TrialsTracker even better than current ClinicalTrials.gov data
Here at the DataLab we are a truly multidisciplinary team: clinicians, academics and software engineers, working together to produce tools, as well as papers. This is … [Read More...] about Welcoming our new DataLab team member, Darren Smyth: a lawyer!
When we launched our FDAAA TrialsTracker we wanted to produce a tool that would improve clinical trial reporting, rather than another repetitive academic journal paper that … [Read More...] about Our FDAAA TrialsTracker is already helping to get new trials reported!
Price Concessions – starting to reduce? The latest price concession information for January has been released by the PSNC (in fact, two sets of data in quick succession). … [Read More...] about OpenPrescribing February Newsletter
Now that we’ve launched our FDAAA TrialsTracker, we plan on occasionally taking a closer look at some of the trials that go unreported. Our first blog was about a trial … [Read More...] about Why is this trial due to report?
With the launch of our FDAAA TrialsTracker, applicable trials that have failed to report their results on ClinicalTrials.gov are starting to appear. If you go here on our … [Read More...] about Unreported Trial of the Week: NCT01846221
This week, we launched our FDAAA TrialsTracker which gives you a live look at whether individual sponsors and trialists are meeting their responsibility to report the results … [Read More...] about The FDAAA TrialsTracker is Live!
The latest price concession information for January has been released by the PSNC (in fact, two sets of data in quick succession). The PSNC have also stated that they are … [Read More...] about Price Concessions – starting to reduce? UPDATED
We've been thinking in the DataLab about doing stories, using our prescribing data, to go with landmark clinical trials and systematic reviews. Here's an example. A new … [Read More...] about Omega-3 isn’t very effective: using prescribing data to explore the impact of trials, reviews, and guidelines
New Year – same Price Concessions issues… Everyone at the EBM DataLab wishes you a very Happy New Year! Unfortunately, the NHS is still having the same problems in … [Read More...] about OpenPrescribing January Newsletter
Everyone at the EBM DataLab wishes you a very Happy New Year! Unfortunately, the NHS is still having the same problems in sourcing generics. The PSNC have just announced … [Read More...] about New Year – same Price Concessions issues…
Many people I’ve spoken to aren’t aware that gluten-free foods can be prescribed, but it happens quite extensively in an effort to help patients with coeliac disease adhere to … [Read More...] about Trends and variation in gluten-free food prescribing
In our second full year of existence we produced even more exciting outputs and continued to grow. You can see the team on our website: Emma-Jane has been our project manager … [Read More...] about 2017 Round-Up
We've taken a quick look at the data to see why, despite the number of price concession lines have increased to 91 in November, the estimated total excess cost has reduced. … [Read More...] about Price Concessions – why are the excess costs lower in November than October 2017?
The PSNC has published the list today of Price Concessions for November 2017. The list is the biggest yet, at 91 lines. We've taken a first stab at calculating the … [Read More...] about Price Concessions Estimate for November 2017 – CCG data
We have been writing a lot recently about the effect of price concessions on the NHS primary care drugs bill, and on the problems community pharmacy are facing. We've been … [Read More...] about Price concessions data for CCGs, including October 2017 estimate
Today we've released our new Drug Tariff viewer. It was a dataset that we previously didn't hold, but thought that it would be useful to turn into a graphical viewer for … [Read More...] about Getting the data for the Drug Tariff tool (*sigh*)
The Drug Tariff, published on behalf of the Department of Health and updated monthly, is a strange and mysterious document, written largely in legalese, and understood by … [Read More...] about New interactive OpenPrescribing tool: Explore Changes in the Drug Tariff (and out of stock medicines) back to 2010!
There has been an interesting and concerning story in The Times today regarding shortages on a number of commonly-used medicines and a corresponding increase in the … [Read More...] about Drug shortages and “Price Concessions” – how much is it costing the NHS?
New: Analyse page no longer needs a denominator One of the most common requests we receive is to be able to use the analyse page without needing to select a denominator, so … [Read More...] about OpenPrescribing December Newsletter
Long Term Trends Tool! All prescribing, 1998-2016 We have created a new interactive tool for exploring the national Prescribing Cost Analysis (PCA) data, allowing you to … [Read More...] about OpenPrescribing News
We have created a new interactive tool for exploring the national Prescribing Cost Analysis (PCA) data, allowing you to investigate prescribing trends going back to 1998. The … [Read More...] about New OpenPrescribing tool: long-term prescribing trends, back to 1998!
We send out monthly newsletters for OpenPrescribing, detailing new features and updates, which you can sign up for here. Our latest issue is below: Low Priority … [Read More...] about OpenPrescribing October Newsletter
Today we launch another exciting new feature on OpenPrescribing. NHS England recently shared a list of 19 classes of treatment which they think should not be prescribed by … [Read More...] about Which GPs are prescribing the treatments advised against by NHS England?
We were at Oxford University's Curiosity Carnival, an event featuring researchers from all disciplines enthusiastically explaining their work to members of the public in an … [Read More...] about Publication Bias: IN CAKE FORM. DataLab at the Curiosity Carnival
Today we launch another new feature on OpenPrescribing. As you will probably know, we have various standard prescribing measures which show how a practice or CCG is … [Read More...] about See Data on the Individual Drugs in our Prescribing Measures
At OpenPrescribing, we provide tools for analysing prescribing behaviour in primary care in the NHS in England. If you work with prescribing data, you may have noticed that … [Read More...] about What is a Dormant GP practice, and why are they prescribing?
Today we are launching something very exciting: a new tool that identifies over £100m in new prescribing cost savings for the NHS. The average practice can save £50,166 a year … [Read More...] about Our New Tool Finds Over £100m in New Cost Savings for the NHS
We've recently added the option to download your results from the Analyse searches you complete on OpenPrescribing. There are now three ways to download data from the site. … [Read More...] about Downloading data from OpenPrescribing
Recently, we've been experimenting with integrating the Dictionary of medicines and devices (dm+d) into our prescribing data. dm+d is the standard dictionary for the medicines … [Read More...] about Prescribing Data: Using the Dictionary of medicines and devices
OpenPrescribing takes open datasets from NHS Digtal and NHS Business Services Authority, and makes it easy for people to explore the prescribing dataset. We also use this … [Read More...] about Prescribing Data: BNF Codes
Today NHS England announced it is reviewing the prescribing of medicines which it deems to be “ineffective, unnecessary [and] inappropriate for prescription on the NHS”. We … [Read More...] about ‘Low Value’ Prescription Items
We launched our e-mail alerts on OpenPrescribing to help people keep track of prescribing trends at their GP Practice or CCG. Our alerts send you a monthly e-mail highlighting … [Read More...] about OpenPrescribing E-mail Alerts
We've been spending some time at OpenPrescribing designing a set of new measures to identify interesting variations in prescribing behaviour across the country. We've … [Read More...] about OpenPrescribing – new measures now available
OpenPrescribing was featured in a recent TARGET antibiotic webinar, which shows how you can use the site to explore antibiotic prescribing in your local CCG or GP practice. It … [Read More...] about OpenPrescribing – TARGET Antibiotic webinar
In our first full year of existence we've grown fast, recruiting lots of new staff. You can see us all on our new website: Lydia our project manager started in the Spring, as … [Read More...] about EBM DataLab 2016 Round-Up
How do you know if your product is really working for users? You can guess, you can ask them, or best of all, you can watch them actually using it. With OpenPrescribing, we … [Read More...] about How to run user testing, and what we learned from doing it on OpenPrescribing